Literature DB >> 6198303

Immunological studies of patients with tumours of the prostate and bladder (a retrospective analysis).

I Romics, J Fehér, J Horváth.   

Abstract

A total of 25 patients with bladder tumour and 35 with prostatic tumour were tested for humoral and cellular immune responsiveness in 1977. Information on the subsequent course of disease was collected 5 years later and confronted with the results of these tests. The most marked deviations in the values of acute-phase proteins, complement and lymphocyte transformation tests were found in those patients who had died within the first year of the investigations. The results approached or attained the normal values parallel with the survival times. The parameters studied thus seem to lend themselves to diagnostic and monitoring purposes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198303     DOI: 10.1007/bf02082554

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Serum proteins in prostatic cancer. III. Relationship of levels of immunoglobulins and complement to clinical stage of disease.

Authors:  R J Ablin
Journal:  Urology       Date:  1976-01       Impact factor: 2.649

2.  Serum immunoglobulins in genitourinary malignancies.

Authors:  J D Schmidt; T L Feldbush; S H Weinstein; W W Bonney
Journal:  J Urol       Date:  1976-03       Impact factor: 7.450

3.  T lymphocytes in bladder and prostatic cancer patients.

Authors:  W J Catalona; C Potvin; P B Chretien
Journal:  J Urol       Date:  1974-09       Impact factor: 7.450

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  "Immunostaging" of patients with prostatic cancer: correlation of "immunostage" and clinical stage. An interim report.

Authors:  R J Ablin; P D Guinan; B Sundar; I M Bush
Journal:  Curr Ther Res Clin Exp       Date:  1976-11

6.  An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer.

Authors:  K Trautner; E H Cooper; S Haworth; A M Ward
Journal:  Scand J Urol Nephrol       Date:  1980

7.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

8.  A comparison of serum immunoglobulins from patients with non-neoplastic prostates and prostatic carcinoma.

Authors:  F A Deture; S L Deardourff; H E Kaufman; Y M Centifanto
Journal:  J Urol       Date:  1978-10       Impact factor: 7.450

Review 9.  Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.

Authors:  D J Laurence; A M Neville
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

10.  Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.

Authors:  A M Ward; E H Cooper; R Turner; J A Anderson; A M Neville
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more
  1 in total

1.  Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.

Authors:  Kathrin Bausch; Elisa Roth; Stefan Heinz; David Horst; Susanne Mathia; Tatjana Vlajnic; Lukas Bubendorf; Timm Westhoff; Christian Wetterauer; Hans Helge Seifert; Jan Ebbing
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.